Form 10-Q Cigna Group For: Sep 30

Go back to Form 10-Q Cigna Group For: Sep 30

CIGNA (CI) PT Raised to $394 at Piper Sandler

November 4, 2024 4:04 PM EST

Piper Sandler analyst Jessica Tassan raised the price target on CIGNA (NYSE: CI) to $394.00 (from $392.00) while maintaining a Overweight rating.

The analyst comments "CI reported a pharmacy-led 3Q24 adjusted EPS beat and reiterated adjusted CY24 guidance. Notwithstanding the asset sale at Cigna Healthcare and... More

CIGNA (CI) PT Lowered to $406 at Jefferies

November 1, 2024 5:45 AM EDT

Jefferies analyst David Windley lowered the price target on CIGNA (NYSE: CI) to $406.00 (from $422.00) while maintaining a Buy rating.

The analyst comments "To our ears, the response to HUM headlines has been consistent (on our Sept NDR and the call): not... More